Thresholds in chemical respiratory sensitisation

Toxicology

Volumn 333, Issue , 2015, Pages 179-194

  Cochrane, Stella A ^a   Arts, Josje H E ^b   Ehnes, Colin ^c   Hindle, Stuart ^d   Hollnagel, Heli M ^d   Poole, Alan ^e   Suto, Hidenori ^f   Kimber, Ian ^g  

^a UNILEVER RESEARCH   (United Kingdom)

^b AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

^c BASF SE   (Germany)

^d DOW EUROPE GMBH   (Switzerland)

^e European Centre for Ecotoxicology and Toxicology of Chemicals   (Belgium)

^f SUMITOMO CHEMICAL CO LTD   (Japan)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemical respiratory allergy; Hazard characterisation; Occupational asthma; Respiratory sensitisation; Sensitising potency; Thresholds

Indexed keywords

ACID ANHYDRIDE; GLUTARALDEHYDE; IMMUNOGLOBULIN E; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5;

ANTIBODY PRODUCTION; CHEMICAL RESPIRATORY ALLERGY; CYTOKINE PRODUCTION; EXPOSURE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LOCAL LYMPH NODE ASSAY; LYMPHOCYTE PROLIFERATION; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RESPIRATORY SENSITIZATION; RESPIRATORY SYSTEM; RESPIRATORY TRACT ALLERGY; REVIEW; RISK FACTOR; SENSITIZATION; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; ENVIRONMENTAL MONITORING; IMMUNOLOGY; LUNG; OCCUPATIONAL ASTHMA; OCCUPATIONAL HEALTH; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY HYPERSENSITIVITY; RISK ASSESSMENT; TOXICOLOGY;

ANIMALIA;

ANIMALS; ASTHMA, OCCUPATIONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MONITORING; HUMANS; INHALATION EXPOSURE; LUNG; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RESPIRATORY HYPERSENSITIVITY; RISK ASSESSMENT; RISK FACTORS; TOXICOLOGY;

EID: 84929313455     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2015.04.010     Document Type: Review

References (153)

1. Adenuga D., Woolhiser M.R., Gollapudi B.B., Boverhof D.R. Differential gene expression responses distinguish contact and respiratory sensitisers and non-sensitising irritants in the local lymph node assay. Toxicol. Sci. 2012, 126:413-425.
2. Apter A.J. Advances in the care of adults with asthma and allergy. J. Allergy Clin. Immunol. 2008, 121:839-844.
3. Arts J.H.E., Kuper C.F. Approaches to induce and elicit respiratory allergy: impact of route and intensity of exposure. Toxicol. Lett. 2003, 140-141:213-222.
4. Arts J.H.E., Droge S.C.M., Spanhaak S., Bloksma N., Pennicks A.H., Kuper C.F. Local lymph node activation and IgE responses in Brown Norway and Wistar rats after dermal application of sensitizing and non-sensitizing chemicals. Toxicology 1997, 117:229-237.
5. Arts J.H.E., Kuper C.F., Spoor S.M., Bloksma N. Airway morphology and function of rats following dermal sensitization and respiratory challenge with low molecular weight chemicals. Toxicol. Appl. Pharmacol. 1998, 152:66-76.
6. Arts J.H.E., Mommers C., de Heer C. Dose-response relationships and threshold levels in skin and respiratory allergy. Crit. Rev. Toxicol. 2006, 36:219-251.
7. Arts J.H.E., de Jong W.H., van Triel J.J., Schijf M.A., de Klerk A., van Loveren H., Kuper C.F. The respiratory local lymph node assay as a tool to study respiratory sensitisers. Toxicol. Sci. 2008, 106:423-434.
8. Bakerly N.D., Moore V.C., Vellore A.D., Jaakkola M.S., Robertson A.S., Burge P.S. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup. Med. 2008, 58:169-174.
9. Ballmer-Weber B.K., Fernandez-Rivas M., Beyer K., Defernez M., Sperrin M., Mackie A.R., Salt L.J., Hourihane J.O., Asero R., Belohlavkova S., Kowalski M., de Blay F., Papadopoulos N.G., Clausen M., Knulst A.C., Roberts G., Popov T., Sprikkelman A.B., Dubakiene R., Vieths S., van Ree R., Crevel R., Mills E.N. How much is too much? Threshold dose distributions for 5 food allergens. J. Allergy Clin. Immunol. 2015, 135:964-971.
10. Basketter D.A., Blaikie L., Dearman R.J., Kimber I., Ryan C.A., Gerberick G.F., Harvey P., Evans P., White I.R., Rycroft R.J.G. Use of the local lymph node assay for estimation of relative contact allergenic potency. Contact Dermatitis 2000, 42:244-348.
11. Basketter D.A., Kimber I. Assessing the potency of respiratory allergens: uncertainties and challenges. Regul. Toxicol. Pharmacol. 2011, 61:365-372.
12. Basketter D.A., Broekhuizen C., Fieldsend M., Kirkwood S., Mascarenhas R., Maurer K., Pedersen C., Rodriguez C., Schiff H.-E. Defining occupational consumer exposure limits for enzyme protein respiratory allergens under REACH. Toxicology 2010, 268:165-170.
13. Basketter D.A., Berg N., Kruszewski F.H., Sarlo K., Concoby B. Relevance of sensitization to occupational allergy and asthma in the detergent industry. J. Immunotoxicol. 2012, 9:314-319.
14. Beckett W.S. The epidemiology of occupational asthma. Eur. Respir. J. 1994, 7:161-164.
15. Bello D., Herrick C.A., Smith T.J., Woskie S.R., Streicher R.P., Cullen M.R., Liu Y., Redlich C.A. Skin exposure to isocyanates: reasons for concern. Environ. Health Perspect. 2007, 115:328-335.
16. Bernstein D.I., Roach D.E., McGrath K.G., Larsen R.S., Zeiss C.R., Patterson R. The relationship of airborne trimellitic anhydride concentrations to trimellitic anhydride-induced symptoms and immune responses. J. Allergy Clin. Immunol. 1983, 72:709-713.
17. Bernstein D.I., Korbee L., Stauder T., Bernstein J.A., Scinto J., Herd Z.L., Berstein I.L. Clinical aspects of allergic disease: the low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J. Allergy Clin. Immunol. 1993, 92:387-396.
18. Blaikie L., Morrow T., Wilson A.P., Hext P., Hartop P.J., Rattray N.J., Woodcock D., Botham P.A. A two-centre study for the evaluation of an animal model for the assessment of the potential of small molecular weight chemicals to cause respiratory allergy. Toxicology 1995, 96:37-50.
19. Bolm-Audorff U., Bienfait H.G., Buckhard J., Bury A.H., Merget R., Pressel G., Schultze-Weringhaus G. Prevalence of respiratory allergy in a platinum refinery. Int. Arch. Occup. Environ. Health 1992, 64:257-260.
20. Botham P., Hext P.M., Rattray N.J., Walsh S.T., Woodcock D.R. Sensitisation of guinea pigs by inhalation exposure to low molecular weight chemicals. Toxicol. Lett. 1988, 41:159-173.
21. Botham P.A., Rattray N.J., Woodcock D.R., Walsh S.T., Hext P.M. The induction of respiratory allergy in guinea pigs following intradermal injection of trimellitic anhydride: a comparison of the response to 2,4-dinitrochlorobenzene. Toxicol. Lett. 1989, 47:25-39.
22. Boverhof D.R., Billington R., Gollapudi B.B., Hotchkiss J.A., Krieger S.M., Poole A., Wiescinski C.M., Woolhiser M.R. Respiratory sensitisation and allergy: current research approaches and needs. Toxicol. Appl. Pharmacol. 2008, 226:1-13.
23. Bruckner H.C., Avery S.B., Stetson D.M., Dodson V.M., Ronayne J.J. Clinical and immunologic appraisal of workers exposed to diisocyanates. Arch. Environ. Health 1986, 16:619-625.
24. Bugler, J., Clark, R.L., Hill, I.D., McDermott, M. 1991. The acute and long-term respiratoryeffects of aromatic diisocyanates. A five year longtitudinal study of polyurethane foam workers. International Isocyanate Institute Report 10848, Manchester, UK.
25. Bullock J. Chloroplatinate Toxicity: Use and Misunderstanding of Merget 2010, International Precious Metal Institute.
26. Calverley A.E., Rees D., Dowdeswell R.J., Linnett P.J., Kielkowski D. Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup. Environ. Med. 1995, 52:661-666.
27. Cassidy L.D., Molenaar D.M., Hattaway J.A., Feeley T.M., Cummings B.J., Simpson P., Li S.-H. Trends in pulmonary functionand prevalence of asthma in hexamethylene diisocyanate workers during a 19 year period. J. Occup. Environ. Med. 2010, 52:988-994.
28. Cohen N.L., Patton C.M. Worker safety and glutaraldehyde in the gastrointenstinal laboratory environment. Gastroenterol. Nurs. 2006, 29:100-104.
29. Cristaudo A., Sera F., Severino V., De Rocco M., Di Lella E., Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005, 60:159-164.
30. De Jong W.H., Arts J.H.E., de Klerk A., Schijf M.A., Ezendam J., Kuper C.F., van Loveren H. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology 2009, 261:103-111.
31. Dearman R.J., Kimber I. Cytokine fingerprinting: characterization of chemical allergens. Methods 1999, 19:56-63.
32. Dearman R.J., Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J. Appl. Toxicol. 2001, 21:153-163.
33. Dearman R.J., Basketter D.A., Kimber I. Variable effects of chemical allergens on serum IgE concentration in mice. Preliminary evaluation of a novel approach to the identification of respiratory sensitizers. J. Appl. Toxicol. 1992, 12:317-323.
34. Dearman R.J., Basketter D.A., Blaikie L., Clark E.D., Hilton J., House R.V., Ladics G.S., Loveless S.E., Mattis C., Sailstad D.M., et al. The mouse IgE test: interlaboratory evaluation and comparison of BALB/c and C57BL/6 strain mice. Toxicol. Meth. 1998, 8:69-85.
35. Dearman R.J., Basketter D.A., Kimber I. Selective induction of type 2 cytokines following topical exposure of mice to platinum salts. Food Chem. Toxicol. 1998, 36:199-207.
36. Dearman R.J., Filby A., Humphreys I.R., Kimber I. Interleukins 5 and 13 characterize immune responses to respiratory sensitizing acid anhydrides. J. Appl. Toxicol. 2002, 22:317-325.
37. Dearman R.J., Basketter D.A., Kimber I. Inter-relationships between different classes of chemical allergens. J. Appl. Toxicol. 2013, 33:558-565.
38. Di Stefano F., Siriruttanapruk S., McCoach J., Burge P.S. Glutaraldehyde: an occupational hazard in the hospital setting. Allergy 1999, 54:1105-1109.
39. Dik S., Ezendam J., Cunningham A.R., Carrasquer C.A., Van Loveren H., Rorije E. Evaluation of in silico models for the identification of respiratory sensitizers. Toxicol. Sci. 2014, 142:385-394.
40. Drexler H., Jonsson B.A., Goen T., Nielsen J., Lakemeyer M., Welinder H. Wxposure assessment and sensitisation in workers exposed to organic anhydrides. Int. Arch. Occup. Environ. Health 2000, 73:228-234.
41. ECHA (European Chemical Agency), 2012. Document: CA/60/2012, Helsinki.
42. Enoch S.J., Roberts D.W., Cronin M.T.D. Electrophilic reaction chemistry of low molecular weight respiratory sensitizers. Chem. Res. Toxicol. 2009, 22:1447-1453.
43. Enoch S.J., Roberts D.W., Cronin M.T.D. Mechanistic category formation for prediction of respiratory sensitization. Chem. Res. Toxiol. 2010, 23:1547-1555.
44. Enoch S.J., Seed M.J., Roberts D.W., Cronin M.T., Stocks S.J., Agius R.M. Development of mechanism-based structural alerts for respiratory sensitization hazard identification. Chem. Res. Toxicol. 2012, 25:2490-2498.
45. Environmental Protection Agency (EPA), 2009. Draft toxicological review of halogenated platinum salts and platinum compounds. In support of the summary information in the Integrated Risk Information System (IRIS).
46. European Commission (SCOEL), 2001. Recommendations from the Scientific Committee on Occupational Exposure Limits for platinum and platinum compounds. SCOEL/SUM/150.
47. Farraj A.K., Harkema J.R., Kaminski N.E. Topical application versus intranasal instillation: a qualitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice. Toxicol. Sci. 2006, 92:321-328.
48. Farraj A.K., Boykin E., Haykal-Coates N., Gavett S.H., Doerfler D., Selgrade M.K. Th2 cytokines in skin draining lymph nodes and IgE do not predict airway hypersensitivity to intranasal isocyanate exposure in mice. Toxicol. Sci. 2007, 100:99-108.
49. Friedman-Jimenez G., Beckett W.S., Szeinuk J., Petsonk E.L. Clinical evaluation management, and prevention of work-related asthma. Am. J. Ind. Med. 2000, 37:121-141.
50. Gannon P.F., Bright P., Campbell M., O'Hickey S.P., Burge P.S. Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and X ray departments. Thorax 1995, 50:156-159.
51. Gee J., Morgan W.K.C. A 10-year follow-up studyof a group of workers exposed to isocyanates. J. Occup. Med. 1985, 27:15.
52. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81:332343.
53. Griem P., Goebel C., Scheffler R. Proposal for a risk assessment methodology for skin sensitisation based on sensitisation potency data. Regul. Toxicol. Pharmacol. 2003, 38:269-290.
54. HSE Asthmagen?. Critical Assessments of the Evidence for Agents Implicated in Occupational Asthma 2001, Health and Safety Executive.
55. Hathaway J.A., DeWilde A., Shepperly D.C., Nguyen L.T., Johnson J.E. Evaluation of pulmonary function in workers exposed to hexamethylene diisocyanate. J. Occup. Environ. Med. 1999, 41:378-383.
56. Health Council of the Netherlands (DECOS), 2008. Platinum and platinum compounds. Health based recommended occupational exposure limit.
57. Health Council of the Netherlands Cyclic Acid Anhydrides- Health-based Recommended Occupational Exposure Limit 2010, The Hague: Health Council of the Netherlands, publication no: 2010/020SH, ISBN: 978-90-5549-782-9.
58. Hilton J., Dearman R.J., Basketter D.A., Kimber I. Identification of chemical respiratory allergens: dose-response relationships in the mouse IgE test. Toxicol. Methods 1995, 5:51-60.
59. Hilton J., Dearman R.J., Boylett M.S., Fielding I., Basketter D.A., Kimber I. The mouse IgE test for the identification of potential chemical respiratory allergens. J. Appl. Toxicol. 1996, 16:165-170.
60. Holsapple M.P., Jones D., Kawabata T.T., Kimber I., Sarlo K., Selgrade M.K., Shah J., Woolhiser M.R. Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 2006, 91:4-13.
61. Hopkins J.E., Naisbitt D.J., Kitteringham N.R., Dearman R.J., Kimber I., Park B.K. Selective haptenation of cellular and extracellular protein by chemical allergens: association with cytokine polarization. Chem. Res. Toxicol. 2005, 18:375-381.
62. Huang J., Wang X., Chen B., Ueda M., Aoyama K., Matsushita T. Immunological effects of toluene diisocyanate exposure on painters. Arch. Environ. Contam. Toxicol. 1991, 21:607-611.
63. Isola D., Kimber I., Sarlo K., Lalko J., Sipes I.G. Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty?. J. Appl. Toxicol. 2008, 28:249-253.
64. Johnson V.J., Reynolds J.S., Wang W., Fluharty K., Yucesoy B. Inhalation of ortho-phthalaldehyde vapour causes respiratory sensitization in mice. J. Allergy (Cairo) 2011, 2011:751052.
65. Jones M., Cullinan P., Durham S., Newman Taylor A. Cellular aspects of occupational asthma: immunological studies in isocyanate exposed subjects. Research Reports Series 2003, HSE Books.
66. Jones M.G., Nielsen J., Welch J., Harrs J., Welinder H., Bensryd I., Skerfving S., Welsh K., Venables K.M., Newman Taylor A. Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acid anhydrides. Clin. Exp. Allergy 2004, 34:812-816.
67. Karol M.H., Hauth B.A., Riley E.J., Magreni C.M. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs. Toxicol. Appl. Pharmacol. 1981, 58:221-230.
68. Karol M.H. Survey ofindustrial workersfor antibodies to toluene diisocyanate. J. Occup. Med. 1981, 23:741-747.
69. Karol M.H. Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure. Toxicol. Appl. Pharmacol. 1983, 68:229-241.
70. Karol M.H. Respiratory effects of inhaled isocyanates. CRC Crit. Rev. Toxicol. 1986, 16:349-379.
71. Kimber I., Basketter D.A. Categorisation of protein respiratory allergens: the case of Subtilisin. Regul. Toxicol. Pharmacol. 2014, 68:488-492.
72. Kimber I., Dearman R.J. Cell and molecular biology of chemical allergy. Clin. Rev. Allergy Immunol. 1997, 15:145-168.
73. Kimber I., Dearman R.J. Chemical respiratory hypersensitivity: an introduction. Toxicology of Chemical Respiratory Hypersensitivity 1997, 1-6. Taylor & Francis, London. I. Kimber, R.J. Dearman (Eds.).
74. Kimber I., Dearman R.J. Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 2002, 181-182:311-315.
75. Kimber I., Basketter D.A., Berthold K., Butler M., Garrigue J.L., Lea L.J., Newsome C., Roggeband R., Steiling W., Stropp G., Waterman S., Wiemann C. Skin sensitisation testing in potency and risk assessment. Toxicol. Sci. 2001, 59:198-208.
76. Kimber I., Dearman R.J., Basketter D.A., Ryan C.A., Gerberick G.F. The local lymph node assay: past present and future. Contact Dermatitis 2002, 47:315-328.
77. Kimber I., Agius R., Basketter D.A., Corsini E., Cullinan P., Dearman R.J., Gimenez-Arnua E., Greenwell L., Hartung T., Kuper F., Maestrelli P., Roggen E., Rovida C. Chemical respiratory allergy: opportunities for hazard identification and characterisation. The Report and Recommendations of ECVAM Workshop 60 2007, 35:243-265. ATLA.
78. Kimber I., Basketter D.A., Gerberick G.F., Ryan C.A., Dearman R.J. Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 2011, 120(Suppl. 1):S238-S268.
79. Kimber I., Basketter D.A., Thyssen J.P., Dearman R.J., McFadden J.P. Chemical allergy in humans: fresh perspectives. J. Immunotoxicol. 2013, 11:203-204.
80. Kimber I., Dearman R.J., Basketter D.A. Diisocyanates, occupational asthma and IgE antibody: implications for hazard identification. J. Appl. Toxicol. 2014, 34:1071-1077.
81. Kimber I., Dearman R.J., Basketter D.A., Boverhof D.R. Chemical respiratory allergy: reverse engineering an adverse outcome pathway. Toxicology 2014, Epub ahead of print.
82. Kimber I., Griffiths C.E.M., Basketter D.A., McFadden J.P., Dearman R.J. Epicutaneous exposure to proteins and skin immune function. Eur. J. Dermatol. 2014, 24:10-14.
83. Kimber I. Chemical respiratory allergy: exposure and dose-response relationships. Allergic Hypersensitivities Induced by Chemicals. Recommendations for Prevention 1996, 139-147. CRC Press, Boca Raton. J.G. Vos, M. Younes, E. Smith (Eds.).
84. Kroes R., Galli C., Munro I., Schilter B., Tran L., Walker R., Würtzen G. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem. Toxicol. 2000, 38:255-312.
85. Lack G. Update on risk factors for food allergy. J. Allergy Clin. Immunol. 2012, 129:1187-1197.
86. Lalko J.F., Kimber I., Dearman R.J., Gerberick G.F., Sarlo K., Api A.M. Chemical reactivity measurements: potential for characterization of respiratory chemical allergens. Toxicol. In Vitro 2011, 25:433-445.
87. Lalko J.F., Kimber I., Gerberick G.F., Foertsch L.M., Api A.M., Dearman R.J. The direct peptide reactivity assay: selectivity of chemical respiratory allergens. Toxicol. Sci. 2012, 129:421-431.
88. Lalko J.F., Dearman R.J., Gerberick G.F., Troutman J.A., Api A.M., Kimber I. Recativity of chemical respiratory allergens in the peroxidase peptide reactivity assay. Toxicol. In Vitro 2013, 27:651-661.
89. Lalko J.F., Kimber I., Dearman R.J., Api A.M., Gerberick G.F. The selective peptide reactivity of chemical respiratory allergens under competitive and non-competitive conditions. J. Immunotoxicol. 2013, 10:292-301.
90. Linnett P.J., Hughes E.G. Twenty years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: the importance of chemical speciation. Occup. Environ. Med. 1999, 56:191-196.
91. Liss G.M., Buyantseva L., Luce C.E., Ribeiro M., Manno M., Tarlo S.M. Work-related asthma in healthcare in Ontario. Am. J. Ind. Med. 2011, 54:278-284.
92. Manetz T.C., Pettit D.A., Meade B.J. The determination of draining lymph node cell cytokine mRNA levels in BALB/cmice following dermal sodium lauryl sulphate dinitrofluorobenzene, and toluene diisocyanate exposure. Toxicol. Appl. Pharmacol. 2001, 171:174-183.
93. McSharry C., Anderson K., Bourke S.J., Boyd G. Takes your breath away -the immunology of allergic alveolitis. Clin. Exp. Immunol. 2002, 128:3-9.
94. Merget R., Kulzer R., Dierkes-Globisch A., Breitstadt R., Gebler A., Kniffka A., Artelt S., Koenig H.-P., Alt F., Vormberg R., Baur X., Schultze-Werninghaus G. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J. Allergy Clin. Immunol. 2000, 105:364-370.
95. Miller R.L., Ho S.M. Environmental epigenetics and asthma: current concepts and call for studies. Am. J. Crit. Care Med. 2008, 177:567-573.
96. Musk A.W., Peters J.M.L., Di Berardinis L., Murphy R.L.H. Absence of respiratory effects in subjects exposed to low concentrations of TDI an MDI. J. Occup. Med. 1982, 24:746-750.
97. NHLBI Guidelines for the diagnosis and management of asthma. national heart, lung and blood institute. National asthma education program. Expert panel report. J. Allergy Clin. Immunol. 2015, 88:425-534.
98. Nemery B., Lenaerts L. Exposure to methylene diphenyl diisocyanate in coal mines. Lancet 1993, 341:318.
99. Newell L., Polak M.E., Perera J., Owen C., Boyd P., Pickard C., Howarth P.H., Healy E., Holloway J.W., Friedmann P.S., Arden-Jones M.R. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J. Invest. Dermatol. 2013, 133:2372-2380.
100. Newman Taylor A.J., Cullinan P., Lympany P.A., Harris J.M., Dowdeswell R.J., Du Bois R. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am. J. Respir. Crit. Care Med. 1999, 160:435-438.
101. Nielsen J., Welinder H., Jonnson B., Axmon A., Rylander L., Skerfving S. Exposure to hexahydrophthalic and methylhexahydrophthalic anhydrides-dose response for sensitization and airway effects. Scand. J. Work Environ. Health 2001, 27:327-334.
102. Nielsen G.D., Olsen O., Larsen S.T., Løvik M., Poulsen L.K., Glue C., Brandorff N.P., Nielsen P.J. IgE-mediated sensitisation, rhinitis and asthma from occupational exposures. Smoking as a model for airborne adjuvants?. Toxicology 2005, 216:87-105.
103. Nielsen G.D., Larsen S.T., Hansen J.S., Poulsen L.K. Experiences from occupational exposure limits set on aerosols containing allergenic proteins. Ann. Occup. Hyg. 2012, 56:888-900.
104. Ott M.G., Klees J.E., Poche S.L. Respiratory health surveillance in a toluene diisocyanate production until 1967-1997-clinical observations and lung function analyses. Occup. Environ. Med. 2000, 57:43-52.
105. Ouyang B., Bernstein D.I., Lummus Z.L., Ying J., Boulet L.P., Cartier A., Gautrin D., Ho S.M. Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol. Sci. 2013, 133:218-224.
106. Pauluhn J., Eben A. Validation of a non-invasive techniqueto assess immediate or delayed onset respiratory hypersensitivity in guinea pigs. J. Appl. Toxicol. 1991, 11:423-431.
107. Pauluhn J., Mohr U. Experimental approaches to evaluate respiratory allergy in animal models. Exp. Toxicol. Pathol. 2005, 56:203-234.
108. Pauluhn J., Thiel A., Emura M., Mohr U. Respiratory sensitization to diphenyl-methan-4,4'-diisocyanate (MDI) in guinea pigs: impact of particle size on induction and elicitation of response. Toxicol. Sci. 2000, 56:105-113.
109. Pauluhn J., Eidmann P., Freyberger A., Wasinska-Kempka G., Vohr H.W. Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: a comparison of endpoints. J. Appl. Toxicol. 2002, 22:89-97.
110. Pauluhn J., Eidmann P., Mohr U. Respiratory hypersensitivity in guinea pigs sensitized to 1,6-hexamethylene diisocyanate (HDI): comparison of results obtained with the monomer and homopolymers of HDI. Toxicology 2002, 171:147-160.
111. Pauluhn J. Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: analysis of dose-response following topical induction and time course following repeated inhalation challenge. Toxicology 2003, 194:1-17.
112. Peters G., Johnson G.Q., Golembiewski A. Safe use of detergent enzymes in the workplace. Appl. Occup. Environ. Hyg. 2001, 16:389-396.
113. Pham Q.T., Teculescu D., Meyer-Bisch C.J., Mur M. Effects of chronic exposure to diisocyanates. Bull. Eur. Physiopath. Resp. 1988, 23:56-60.
114. Pisaniello D.L., Gun R.T., Tkaczuk M.N., Nitshcke M., Crea J. Glutaraldehyde exposures and symptoms among endoscopy nurses in South Australia. Appl. Occup. Environ. Hyg. 1997, 12:171-177.
115. Plitnick L.M., Loveless S.E., Ladics G.S., Holsapple M.P., Selgrade M.J., Sailstad D.M., Smialowicz R.J. Cytokine profiling for chemical sensitizers: application of the ribonuclease protection assay and effect of dose. Toxicol. Appl. Pharmacol. 2002, 185:228-230.
116. Quint J., Beckett W.S., Campleman S.L., Sutton P., Prudhomme J., Flattery J., Harrison R., Cowan B., Kreutzer R. Primary prevention of occupational asthma: identifying and controlling exposures to asthma-causing agents. Am. J. Ind. Med. 2008, 51:477-491.
117. Rattray N.J., Botham P.A., Hext P.M., Woodcock D.R., Fielding I., Dearman R.J., Kimber I. Induction of respiratory hypersensitivity to diphenylmethane-4,4'-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology 1994, 88:15-30.
118. Rauf-Heimsoth M., Merget R., Rihs H.P., Fohring M., Liebers V., Gellert B., Schultze-Werninghaus W., Baur X. T-cell repertoire expression in workers with occupational asthma due to platinum salt. Eur. Respir. J. 2000, 16:871-878.
119. Redlich C.A., Herrick C.A. Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 2008, 8:115-119.
120. Redlich C.A. Skin exposure and asthma: is there a connection. Proc. Am. Thorac. Soc. 2010, 7:134-137.
121. Rosqvist S., Nielsen J., Welinder H., Rylander L., Lindh C.H., Jonsson B.A. Exposure-response relationships for hexahydrophthalic and methylhexahydrophthalic anhydrides with total plasma protein adducts as biomarkers. Scand. J. Work Environ. Health 2003, 29:297-303.
122. Rovida C., Martin S.F., Vivier M., Weltzien H.U., Roggen E. Advanced tests for skin and respiratory sensitization assessment. ALTEX 2013, 30:231-252.
123. Saito R., Abbas Virji M., Henneberger P.K., Humann M.J., LeBouf R.F., Stanton M.L., Liang X., Stefaniak A.B. Characterization of cleaning and disinfecting tasks and product use among hospital occupations. Am. J. Ind. Med. 2015, 58:101-111.
124. Sarlo K., Clark E.D. A tierapproach for evaluating the respiratory allergenicity of low molecular weight chemicals. Fundam. Appl. Toxicol. 1992, 18:107-114.
125. Sarlo K. Control of occupational asthma and allergy in the detergent industry. Ann. Allergy Asthma Immunol. 2003, 90:32-34.
126. Schneider K., Akkan Z. Quantitative relationship between the local lymph node assay and human skin sensitisation assays. Regul. Toxicol. Pharmacol. 2004, 39:245-255.
127. Seed M., Agius R. Further validation of computer-based prediction of chemical asthma hazard. Occup. Med. 2010, 60:115-120.
128. Seed M.J., Cullinan P., Agius R.M. Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr. Opin. Allergy Clin. Immunol. 2008, 8:103-109.
129. Selgrade M.K., Boykin E.H., Haykal-Coates N., Wollhiser M.R., Wiesconski C., Andrews D.L., Farraj A.K., Doerfler D.L., Gavett S.H. Inconsistencies between cytokine profiles antibody responses, and respiratory hyperresponsiveness following dermal exposure to diisocyanates. Toxicol. Sci. 2006, 94:108-117.
130. Siddiqui S., Morris J., Avery N., Wyand S., Rood D., Silbart L.K. Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma. Clin. Exp. Allergy 2008, 38:1381-1390.
131. Steinfort D.P., Pilmore J., Brenton S., Hart D.H.L. Absence of platinum salt sensitivity in autocatalyst workers exposed to tetraamine platinum dichloride. Occup. Med. 2008, 58:215-218.
132. Sutton P.M., Quint J., Prudhomme J., Flattey J., Materna B., Harrison R. Glutaraldehyde exposure among workers making bioprosthetic heart valves. J. Occup. Eviron. Hyg. 2007, 4:311-320.
133. Tarlo S., Malo J.L. An ATS/ERS report: 100 key questions and needs in occupational asthma. Eur. Resp. J. 2006, 27:607-614.
134. Tarlo S.M., Liss G.M., Dias C., Banks D.E. Assessment of the relationship between isocyanate exposure and occupational asthma. Am. J. Ind. Med. 1997, 32:517-521.
135. Tarlo S.M., Balmes J., Balkissoon R., Beach J., Beckett W., Bernstein D., Blanc P.D., Brooks S.M., Cowl C.T., Daroowalla F., Harber P., Lemiere C., Liss G.M., Pacheco K.A., Redlich C.A., Rowe B., Heitzer J. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest 2008, 134(Suppl. 3):1S-41S.
136. Taylor S.L., Baumert J.L., Kruizinga A.G., Remington B.C., Crevel R.W.R., Brooke-Taylor S., Allen K.J., Houben G. Establishment of Reference Doses for residues of allergenic foods: report of the VITAL Expert Panel. Food Chem. Toxicol. 2014, 63:9-17.
137. Teta J.M., Avashia B.H., Cawley T.J., Yamin A.T. Absence of sensitization and cancer increases among glutaraldehyde workers. Toxic Subst. Mech. 1995, 14:293-305.
138. Toebak M., Moed H., von Blomberg M.B., Bruynzeel D.P., Gibbs S., Scheper R.J., Rustemeyer T. Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermatitis 2006, 55:238-245.
139. Van Och F.M.M., van Loveren H., de Jong W.H., Vandebriel R. Cytokine production inducedby low molecular weiht chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol. Appl. Pharmacol. 2002, 184:46-56.
140. Vandebriel R., CallantCransveld C., Crommelin D., Diamant Z., Glazenburg B., Joos G., Kuper F., Natsch A., Nijkamp F., Noteborn H., Pieters R., Roberts D., Roggen E., Rorije E., Seed M., Sewald K., van den Heuvel R., van Engelen J., Verstraelen S., van Loveren H. Respiratory sensitization: advances in assessing the risk of respiratory inflammation and irritation. Toxicol. In Vitro 2011, 25:1251-1258.
141. Vandenplas O., Lantin A.-C., Alpaos V.D., Larbanois A., Hoet P., Vandeweerdt M., Thimpont J., Speybroeck N. Time trends in occupational asthma in Belgium. Resp. Med. 2011, 105:1364-1372.
142. Venables K.M., Topping M.D., Howe W., Luczynska C.M., Hawkins R., Taylor A.J. Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br. Med. J. 1985, 290:201-204.
143. Vyas A., Pickering S.A.C., Oldham L.A., Francis H.C., Fletcher A.M., Merrett T., Niven R.M. Survey of symptoms respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff. Occup. Environ. Med. 2000, 57:752-759.
144. Warbrick E.V., Dearman R.J., Kimber I. IgG and IgE anibody responses following exposure of Brown Norway rats to trimellitic anhydride: comparison of inhalation and topical exposure. Toxicology 2002, 172:157-168.
145. Warbrick E.V., Dearman R.J., Kimber I. Induced changes in total serum IgE concentration in the Brown Norway rat: potential for identification of chemical respiratory allergens. J. Appl. Toxicol. 2002, 22:1-11.
146. Water A., Beach J., Abramson M. Symptoms and lung function in healthcare personnel exposed to glutaraldehyde. Am. J. Ind. Med. 2003, 43:196-203.
147. Weill H., Butcher B., Dharmarajan V., Glindmeyer H., Jones R., Carr J., Neil C.O., Salvaggio J. Respiratory and Immunologic Evaluation of Isocyanate Exposure in a New Manufacturing Plant 1981, U.S. Department of Health and Human Services. National Institute for Occupational Safety and Health (NIOSH), Publication No: 81-125.
148. Welinder H., Nielsen J., Rylander L., Stahlbom B. A prospective study of the relationship between exposure and specific antibodies in workers exposed to organic acid anhydrides. Allergy 2001, 56:506-511.
149. Wiszniewska M., Walusiak-Skorupa J. Occupational allergy: respiratory hazard in healthcare workers. Curr. Opin. Allergy Clin. Immunol. 2014, 14:113-118.
150. Yokota K., Johyama Y., Yamaguchi K., Takeshita T., Morimoto K. Exposure-response relationships in rhinitis and conjunctivitis caused by methyltetrahydrophthalic anhydride. Int. Arch. Occup. Environ. Health 1999, 72:14-18.
151. Yucesoy B., Johnson V.J., Lummus Z.L., Kissling G.E., Fluharty K., Gautrin D., Malo J.L., Cartier A., Boulet L.P., Sastre J., Quirce S., Tarlo S.M., Cruz M.J., Munoz X., Luster M.I., Bernstein D.I. Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma. Toxicol. Sci. 2012, 129:166-173.
152. Yucesoy B., Johnson V.J., Lummus Z.L., Kashon M.L., Rao M., Bannerman-Thomson H., Frye B., Wang W., Gautrin D., Cartier A., Boulet L.P., Sastre J., Quirce S., Tarlo S.M., Germolec D.R., Luster M.I., Bernstein D.I. Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced asthma. J. Occup. Environ. Med. 2014, 56:382-387.
153. Zhang X.D., Lotvall J., Arakawa H., Welinder H., Skerfving S. Relationship between IgG1 levels and airway responses in guinea pigs actively and passively sensitized to hexahydrophthalic anhydride. Allergy 1998, 53:20-27.